Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

Study Purpose

Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Patient is minimum 18 years old.
  • - Informed Consent in the documentation of clinical and radiological results.
  • - Patient has indication according to Instructions for Use (IFU) - Patient is not pregnant.

Exclusion Criteria:

- Patient's clear unability or unwillingness to participate in follow-up examinations

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT05296889
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Aesculap AG
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

N/A
Principal Investigator Affiliation N/A
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Industry
Overall Status Recruiting
Countries Germany
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Spine Fracture, Degenerative Disc Disease, Spinal Instability, Spinal Tumor, Degenerative Myelopathy
Additional Details

This clinical study is one of the Post market clinical follow-up measures that enables the manufacturer to monitor the clinical safety and performance of the Ennovate® Cervical system. The study enables a quick, but detailed implant documentation, which is of great interest for the current and future users of the internal fixation system targeted in this study. It includes the relevant outcomes to evaluate safety and efficacy of the implant system for various indications in trauma and degenerative disorders.

Arms & Interventions

Arms

: Ennovate® Cervical

Alll patients which were treated with the Ennovate® Cervical system in accordance with the indications given in the instructions for use

Interventions

Device: - posterior stabilization for the cervical spine

The Ennovate® Cervical Spinal System is a posterior stabilization for the cervical and upper-thoracic spine. The implants are used for the posterior monosegmental and multisegmental stabilization of the occipitocervical junction and of the cervical and upper thoracic spine.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

Krankenhaus Ludmillenstift Meppen, Meppen, Niedersachsen, Germany

Status

Not yet recruiting

Address

Krankenhaus Ludmillenstift Meppen

Meppen, Niedersachsen, 49716

Site Contact

Felix Kiepe, Dr.

[email protected]

+497461950

Halle, Sachsen-Anhalt, Germany

Status

Recruiting

Address

Berufsgenossenschaft Klinikum Bergmannstrost Halle / Saale

Halle, Sachsen-Anhalt, 06112

Site Contact

Klaus Röhl, Dr.

[email protected]

+497461950

Städtisches Klinikum Dresden, Dresden, Sachsen, Germany

Status

Not yet recruiting

Address

Städtisches Klinikum Dresden

Dresden, Sachsen, 01076

Site Contact

Philip Gierer, Prof. Dr.

[email protected]

+497461950

Schön Klinik Hamburg Eilbek, Hamburg, Germany

Status

Active, not recruiting

Address

Schön Klinik Hamburg Eilbek

Hamburg, , 22081

Stay Informed & Connected